Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125903003 | 12590300 | 3 | F | 201605 | 20160913 | 20160725 | 20160915 | EXP | US-ALLERGAN-1663600US | ALLERGAN | 53.00 | YR | F | Y | 52.15000 | KG | 20160915 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125903003 | 12590300 | 1 | PS | BOTOX | ONABOTULINUMTOXINA | 1 | Intramuscular | 100 UNITS, UNK | 103000 | POWDER FOR INJECTION | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125903003 | 12590300 | 1 | Migraine |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125903003 | 12590300 | OT |
| 125903003 | 12590300 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125903003 | 12590300 | Blindness | |
| 125903003 | 12590300 | Dehydration | |
| 125903003 | 12590300 | Malaise | |
| 125903003 | 12590300 | Ocular discomfort | |
| 125903003 | 12590300 | Optic nerve disorder | |
| 125903003 | 12590300 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125903003 | 12590300 | 1 | 20160531 | 20160531 | 0 |